Problem is it isn't "PolyNovo’s T1D cure ambitions" unless they buy Beta Cell ( which they previous did with Greenwood/Burton's company that developed BTM). PNV are just a supplier of the mesh in my understanding.
PolyNovo Limited (PolyNovo or Company) will host an investor update webcast, to be streamed live on Friday 16 May at 10.00am AEST, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.015(1.26%) |
Mkt cap ! $811.7M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.21 | $1.17 | $1.824M | 1.538M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 29280 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 10340 | 2 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| PNV (ASX) Chart |